HENNEMAN JOHN B III
SEC CIK 1187572 · EDGAR
BoughtSold
Most active insiders at ANIK, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Griffin Stephen D. | Pres, CEO, Dir | $149.9K | — |
| 2 | HENNEMAN JOHN B III | Dir | $73.3K | — |
| 3 | Fischetti Gary P | Dir | $41.1K | — |
| 4 | Richard Stephen | Dir | — | — |
| 5 | Colleran David | EVP, GC, Corp Sec | — | — |
| 6 | Capper Joseph H | Dir | — | — |
| 7 | McLeod Ian | SVP, CAO, Treas | — | — |
| 8 | Blanchard Cheryl R | Dir | — | — |
| 9 | CONLEY SHERYL L | Dir | — | — |
Transactions 19
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-23 16:30 | 2026-06-18 | ANIK | Anika Therapeutics, Inc. | HENNEMAN JOHN B III | Dir | A - Grant | $0.00 | +10.4K | 65.3K | +19% | $0 | |
| D | 2026-06-17 19:05 | 2026-06-16 | APRE | Aprea Therapeutics, Inc. | HENNEMAN JOHN B III | Dir | A - Grant | $0.00 | +3,135 | 13.4K | +31% | $0 |
| 2026-06-12 18:27 | 2026-06-10 | OFIX | Orthofix Medical Inc. | HENNEMAN JOHN B III | Dir | A - Grant | $0.00 | +15.0K | 105.8K | +16% | $0 | |
| 2026-05-08 16:52 | 2026-05-07 | OFIX | Orthofix Medical Inc. | HENNEMAN JOHN B III | Dir | P - Purchase | $12.26 | +5,000 | 90.8K | +6% | +$61.3K | |
| 2026-05-04 08:34 | 2026-05-01 | ANIK | Anika Therapeutics, Inc. | HENNEMAN JOHN B III | Dir | P - Purchase | $14.66 | +5,000 | 54.9K | +10% | +$73.3K | |
| 2025-06-24 | 2025-06-20 | ANIK | Anika Therapeutics, Inc. | HENNEMAN JOHN B III | Dir | A - Grant | $0.00 | +14.2K | 49.9K | +40% | $0 | |
| 2025-06-23 | 2025-06-18 | OFIX | Orthofix Medical Inc. | HENNEMAN JOHN B III | Dir | A - Grant | $0.00 | +18.8K | 83.7K | +29% | $0 | |
| D | 2025-06-09 | 2025-06-05 | APRE | Aprea Therapeutics, Inc. | HENNEMAN JOHN B III | Dir | A - Grant | $0.00 | +1,045 | 10.2K | +11% | $0 |
| 2024-07-11 | 2024-07-09 | ANIK | Anika Therapeutics, Inc. | HENNEMAN JOHN B III | Dir | A - Grant | $0.00 | +5,771 | 35.7K | +19% | $0 | |
| D | 2024-06-21 | 2024-06-20 | APRE | Aprea Therapeutics, Inc. | HENNEMAN JOHN B III | Dir | A - Grant | $0.00 | +1,045 | 9,184 | +13% | $0 |
| 2024-06-20 | 2024-06-18 | OFIX | Orthofix Medical Inc. | HENNEMAN JOHN B III | Dir | A - Grant | $12.87 | +15.2K | 63.9K | +31% | +$195.0K | |
| D | 2024-03-14 | 2024-03-13 | APRE | Aprea Therapeutics, Inc. | HENNEMAN JOHN B III | Dir | P - Purchase | $7.29 | +6,860 | 8,139 | +536% | +$50.0K |
| D | 2023-08-24 | 2023-08-23 | APRE | Aprea Therapeutics, Inc. | HENNEMAN JOHN B III | Dir | A - Grant | $0.00 | +500 | 1,279 | +64% | $0 |
| 2023-06-16 | 2023-06-14 | ANIK | Anika Therapeutics, Inc. | HENNEMAN JOHN B III | Dir | A - Grant | $0.00 | +6,500 | 29.9K | +28% | $0 | |
| A | 2023-02-09 | 2023-01-05 | OFIX | Orthofix Medical Inc. | HENNEMAN JOHN B III | Dir | A - Grant | $0.00 | +14.4K | 48.8K | +42% | $0 |
| 2023-01-09 | 2023-01-05 | OFIX | Orthofix Medical Inc. | HENNEMAN JOHN B III | Dir | A - Grant | $0.00 | +14.1K | 48.5K | +41% | $0 | |
| D | 2022-08-01 | 2022-07-28 | APRE | Aprea Therapeutics, Inc. | HENNEMAN JOHN B III | Dir | A - Grant | $0.00 | +5,995 | 15.6K | +62% | $0 |
| 2022-06-10 | 2022-06-08 | ANIK | Anika Therapeutics, Inc. | HENNEMAN JOHN B III | Dir | A - Grant | $0.00 | +7,954 | 23.4K | +51% | $0 | |
| D | 2021-07-01 | 2021-06-30 | APRE | Aprea Therapeutics, Inc. | HENNEMAN JOHN B III | Dir | A - Grant | $0.00 | +4,610 | 9,610 | +92% | $0 |
Purchase Sale Sale after option exercise All abbreviations